baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Akari Therapeutics Plc/ US00972G2075 /

29/08/2024 21:49:46	Chg. -	Volume	Bid-	Ask-	High	Low
3.86USD	-	200 Turnover: 772	-Bid Size: -	-Ask Size: -	3.86	3.86

GlobeNewswire 19/08 Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire 19/08 Akari Therapeutics Receives Positive and Constructive Pre-IND Feedback from US FDA for PAS-nomacopan...

GlobeNewswire 05/06 Akari Therapeutics Announces Interim CEO Employment Contract Demonstrating Alignment with Shareholde...

GlobeNewswire 04/06 Akari Therapeutics Secures $7.6 Million in Upsized Financing Round

GlobeNewswire 16/05 Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights

GlobeNewswire 01/05 Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

GlobeNewswire 01/05 Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merge...

GlobeNewswire 15/04 Akari Therapeutics to Present PAS-Nomacopan Pre-Clinical Electroretinography (ERG) Data at ARVO 2024

GlobeNewswire 01/04 Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

GlobeNewswire 15/03 SHAREHOLDER ALERT: The M&A Class Action Launches Investigation of the Merger – SDPI, MINM, SCX, AKTX

GlobeNewswire 15/03 SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates VIVK, MINM, SDPI, AKTX

GlobeNewswire 09/03 INVESTIGATION UPDATE: Halper Sadeh LLC Investigates IGT, AKTX, SDPI, VIVK

GlobeNewswire 08/03 Kuehn Law Encourages VIVK, HES, SDPI, and AKTX Investors to Contact Law Firm

GlobeNewswire 05/03 Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expande...

GlobeNewswire 02/01 Akari Therapeutics Announces Existing Investors Support the Company Through a $2 Million Private Pla...

GlobeNewswire 14/12/2023 Akari Therapeutics to Present at Biotech Showcase 2024

GlobeNewswire 01/12/2023 Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of ...

GlobeNewswire 16/11/2023 Akari Therapeutics Presents Poster on Progress in Pre-Clinical Development of Long-Acting PAS-Nomaco...

GlobeNewswire 06/11/2023 Akari Therapeutics to Present a Poster on Pre-Clinical Development of Long-Acting PAS-Nomacopan as a...

GlobeNewswire 04/10/2023 Presenting on the Emerging Growth Conference 63 Day 2 on October 5 Register Now

GlobeNewswire 03/10/2023 Presenting on the Emerging Growth Conference 63 Day 1 on October 4 Register Now

GlobeNewswire 29/09/2023 Akari Therapeutics Reports First Half 2023 Financial Results and Highlights

GlobeNewswire 27/09/2023 Akari Therapeutics to Present at Emerging Growth Conference

Akari Therapeutics Plc/ US00972G2075 /

If you wish to receive reply to your feedback, please provide your email address.